Happy to announce that Dominik Witzigmann, CEO of NanoVation Therapeutics, will be part of the panel discussion focused on the potential of mRNA technology as a therapeutic platform at the BioFIT Event 2022 Conference in Strasbourg on 29 November.

More info.